Sam-E, Silybin, Vitamin E, Zinc

Verify with FDA CVM →

495 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
495
Total Reports
127
Deaths Reported
2570.0%
Death Rate

Active Ingredients

Sam-E, Silybin, Vitamin E, Zinc

Administration Routes

UnknownOralSubcutaneousOphthalmic

Species Affected

Dog 474
Cat 21

Most Affected Breeds

Retriever - Labrador 126
Shih Tzu 20
Chihuahua 18
Maltese 15
Domestic Shorthair 14
Beagle 13
Retriever - Golden 11
Mixed (Dog) 10
Boxer (German Boxer) 10
Crossbred Canine/dog 10

Most Reported Reactions

Elevated alanine aminotransferase (ALT) 242
Vomiting 193
Elevated serum alkaline phosphatase (SAP) 187
Anorexia 150
Elevated total bilirubin 147
Lethargy (see also Central nervous system depression in 'Neurological') 143
Elevated liver enzymes 131
Other abnormal test result NOS 100
Abnormal ultrasound finding 89
Death by euthanasia 80
Weight loss 80
Icterus 68

Outcome Breakdown

Ongoing
279 (56.1%)
Euthanized
82 (16.5%)
Recovered/Normal
51 (10.3%)
Died
45 (9.1%)
Outcome Unknown
40 (8.0%)

Data Summary

Metric Value
Total adverse event reports 495
Reports involving death 127
Case-fatality rate (reported events) 2570.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Sam-E, Silybin, Vitamin E, Zinc Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 495 adverse event reports referencing Sam-E, Silybin, Vitamin E, Zinc, including 127 reports in which the animal died — a 2570.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Sam-E, Silybin, Vitamin E, Zinc. Reported administration routes include Unknown, Oral, Subcutaneous, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Sam-E, Silybin, Vitamin E, Zinc reports are Dog (474 reports), Cat (21 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (126), Shih Tzu (20), Chihuahua (18) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Sam-E, Silybin, Vitamin E, Zinc are Elevated alanine aminotransferase (ALT) (242), Vomiting (193), Elevated serum alkaline phosphatase (SAP) (187), Anorexia (150). Of the 497 reports with a coded outcome, Ongoing is the leading category at 56.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Sam-E, Silybin, Vitamin E, Zinc.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial